XML 20 R14.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
MEDICARE PART D
 12 Months Ended
Dec. 31, 2019
Insurance [Abstract]  
MEDICARE PART D MEDICARE PART D
As discussed in Note 2, we cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with CMS. The accompanying consolidated balance sheets include the following amounts associated with Medicare Part D as of December 31, 2019 and 2018. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers.
 
 
2019
 
2018
 
 
Risk
Corridor
Settlement
 
CMS
Subsidies/
Discounts
 
Risk
Corridor
Settlement
 
CMS
Subsidies/
Discounts
 
 
(in millions)
Other current assets
 
$
5

 
$
585

 
$
15

 
$
172

Trade accounts payable and accrued expenses
 
(120
)
 
(356
)
 
(103
)
 
(503
)
Net current (liability) asset
 
(115
)
 
229

 
(88
)
 
(331
)
Other long-term assets
 
6

 
—

 
7

 
—

Other long-term liabilities
 
(61
)
 
—

 
(89
)
 
—

Net long-term liability
 
(55
)
 
—

 
(82
)
 
—

       Total net (liability) asset
 
$
(170
)
 
$
229

 
$
(170
)
 
$
(331
)